Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Canadian Rapid Treatment Center of Excellence Opens Second Location Providing Ketamine Treatment for Adults with Depression

Canadian Rapid Treatment Center of Excellence Opens Second Location Providing Ketamine Treatment for Adults with Depression

  • Post published:November 9, 2020
  • Post category:Press Release
Read more about the article Champignon Brands Provides Update on Continuous Disclosure Review

Champignon Brands Provides Update on Continuous Disclosure Review

  • Post published:October 29, 2020
  • Post category:Press Release
Read more about the article Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.

Dr. Roger McIntyre Elected Board Chair of Champignon Brands Inc.

  • Post published:October 5, 2020
  • Post category:Press Release
Read more about the article Champignon Provides Update on Disclosure Review

Champignon Provides Update on Disclosure Review

  • Post published:September 15, 2020
  • Post category:Press Release
Read more about the article Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence

Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence

  • Post published:August 27, 2020
  • Post category:Press Release
Read more about the article Champignon Announces Filing of Business Acquisition Reports and Appointment of Director

Champignon Announces Filing of Business Acquisition Reports and Appointment of Director

  • Post published:July 25, 2020
  • Post category:Press Release
Read more about the article Champignon Provides Corporate Update

Champignon Provides Corporate Update

  • Post published:July 13, 2020
  • Post category:Press Release
Read more about the article Champignon Announces Regulatory Review

Champignon Announces Regulatory Review

  • Post published:June 22, 2020
  • Post category:Press Release
Read more about the article Champignon Brands Served a Cease Trade Order

Champignon Brands Served a Cease Trade Order

  • Post published:June 20, 2020
  • Post category:News
Read more about the article Champignon’s Dr. Mcintyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals

Champignon’s Dr. Mcintyre / Canadian Rapid Treatment Centre of Excellence (CRTCE) Published in Two Peer Reviewed Study Journals

  • Post published:June 19, 2020
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More